[1] |
Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League against rheumatism classification criteria for IgG4-related disease[J]. Ann Rheum Dis,2020,79(1):77-87.
|
[2] |
张文,董凌莉,朱剑,等. IgG4相关性疾病诊治中国专家共识[J]. 中华内科杂志,2021,60(3):192-206.
|
[3] |
费允云,刘燕鹰,董凌莉,等. IgG4相关性疾病诊疗规范[J]. 中华内科杂志,2023,62(10):1161-1171.
|
[4] |
Ameerah Y, Musmar B, Awadghanem A, et al. Autoimmune pancreatitis with IgG-4 cholangiopathy in a pregnant woman: a case report[J]. Radiol Case Rep,2023,18(4):1580-1584.
|
[5] |
Koide H, Shiga A, Komai E, et al. Prednisolone-responsive postpartum IgG4-related hypophysitis[J]. Intern Med,2018,57(3):367-375.
|
[6] |
Wang J, Zeng Y, Gu Y, et al. IgG4-related lung disease manifested as pneumonia in puerperium: a case report[J]. Int J Clin Exp Pathol,2015,8(3):3312-3315.
|
[7] |
Nishioka H, Ito H, Miki T, et al. Lymphocytic adenohypophysitis associated with Rathke′s cleft cyst[J]. Endocr Pathol,1995,6(4):337-343.
|
[8] |
Nishioka H, Shibuya M, Haraoka J. Immunohistochemical study for IgG4-positive plasmacytes in pituitary inflammatory lesions[J]. Endocr Pathol,2010,21(4):236-241.
|
[9] |
Erdei A, Steiber Z, Molnar C, et al. Exophthalmos in a young woman with no graves′ disease-a case report of IgG4-related orbitopathy[J]. BMC Ophthalmol,2018,18(1):1-6.
|
[10] |
张小改,陈国芳,徐书杭,等. IgG4相关性甲状腺疾病新进展[J]. 国际内分泌代谢杂志,2020,40(3):163-168.
|
[11] |
Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease[J]. J Gastroenterol,2003,38(10):982-984.
|
[12] |
Takeshima K, Li Y, Kakudo K, et al. Proposal of diagnostic criteria for IgG4-related thyroid disease[J]. Endocr J,2021,68(1):1-6.
|
[13] |
Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care[J]. Nat Rev Rheumatol,2020,16(12):702-714.
|
[14] |
Akiyama M, Yasuoka H, Yamaoka K, et al. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease[J]. Arthritis Res Ther,2016,18:1-14.
|
[15] |
Nagafuchi Y, Shoda H, Fujio K. Immune profiling and precision medicine in systemic lupus erythematosus[J]. Cells,2019,8(2):1-15.
|
[16] |
Della-Torre E, Rigamonti E, Perugino C, et al. B lymphocytes directly contribute to tissue fibrosis in IgG4- Related Disease[J]. J Allergy Clin Immunol,2020,145(3):968-981,981.e1-981.e14.
|
[17] |
Furukawa S, Moriyama M, Tanaka A, et al. Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz′s disease[J]. Clin Immunol,2015,156(1):9-18.
|
[18] |
Furukawa S, Moriyama M, Miyake K, et al. Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease[J]. Sci Rep,2017,7:1-10.
|
[19] |
Kawakami T, Mizushima I, Yamada K, et al. Abundant a proliferation-inducing ligand (APRIL)-producing macrophages contribute to plasma cell accumulation in immunoglobulin G4-related disease[J]. Nephrol Dial Transplant,2019,34(6):960-969.
|
[20] |
Rotondi M, Carbone A, Coperchini F, et al. IgG4-related thyroid autoimmune disease[J]. Eur J Endocrinol,2019,180(5):R175-183.
|
[21] |
江帆,陈国芳,徐书杭,等. 高IgG4水平Graves病临床特征研究[J]. 中国实用内科杂志,2018,38(1):52-55.
|
[22] |
中华医学会内分泌学分会,中国内分泌代谢病专科联盟,宁光,等. 糖皮质激素类药物临床应用指导原则(2023版)[J]. 中华内分泌代谢杂志,2023,39(4):289-296.
|
[23] |
蒋萌,狄文. 风湿免疫疾病患者妊娠期及哺乳期的用药风险评估[J].国际妇产科学杂志,2020,47(6):657-661.
|
[24] |
Skomsvoll JF, Aasarød K, Salvesen KA, et al. Systemisk lupus erythematosus og svangerskap[J]. Tidsskr Nor Laegeforen,2007,127(6):725-729.
|
[25] |
Levy RA, de Jesús GR, de Jesús NR, et al. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation[J]. Autoimmun Rev,2016,15(10):955-963.
|
[26] |
Martínez López JA, García Vivar ML, Cáliz R, et al. Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding[J]. Reumatol Clin,2017,13(5):264-281.
|
[27] |
张文,李懿莎,刘冬舟,等. 风湿性疾病患者围妊娠期药物使用规范[J]. 中华内科杂志,2021,60(11):946-953.
|